Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Type
5.1.1 Prebiotics
5.1.2 Probiotics
5.1.3 Enzymes
5.1.4 Other Types
5.2 Distribution Channel
5.2.1 Supermarkets/Hypermarkets
5.2.2 Pharmacies and Drugstores
5.2.3 Online Retailers
5.2.4 Other Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 Germany
5.3.2.3 Spain
5.3.2.4 France
5.3.2.5 Italy
5.3.2.6 Russia
5.3.2.7 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 Rest of Asia-Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle-East
5.3.5.1 United Arab Emirates
5.3.5.2 South Africa
5.3.5.3 Rest of Middle-East


6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 Pfizer Inc.
6.4.2 Bayer AG
6.4.3 NOW Health Group Inc.
6.4.4 Alimentary Health Limited
6.4.5 Herbalife International of America Inc.
6.4.6 Amway Corporation
6.4.7 PanTheryx Inc.
6.4.8 The Nature’s Bounty Co.
6.4.9 Organic India
6.4.10 General Nutrition Centers Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS


8 IMPACT OF COVID-19 ON THE MARKET